$GRAL news
The latest GRAL stock news: headlines, filings, AI summaries and sentiment for $GRAL, updated around the clock.
- GRAIL Reports Q3 2026 Results with Increased Test Volumes Amidst Margin Compression
- GRAIL Anticipates Early Q1 2027 FDA Decision for Galleri Test and Updates Revenue Growth Outlook
- GRAIL, Inc. - 8-K Filing
- 2026 Longevity Preparedness Index Reveals Stagnant Readiness Among Americans
- Grail's Stock Surges After FDA Advisory Committee Endorses Multi-Cancer Early Detection Test
- Grail Stock Surges Over 50% After FDA Committee Votes in Favor of Galleri MCED Test
- GRAIL shares rise as FDA panel supports cancer detection test
- FDA advisory panel endorses GRAIL's Galleri as multi-cancer early detection blood test
- GRAIL Shares Rise on Positive FDA Evaluation of Galleri Cancer Test
- Grail CFO Sells 7,900 Shares for $672,000
- Grail Stock Rises in August Following FDA Meeting Announcement
- Shareholders Notified of August 4, 2026 Lead Plaintiff Deadline in Grail Lawsuit
- Class Action Lawsuit Filed Against GRAIL, Inc. Over Alleged Securities Fraud
- GRAIL, Inc. Faces Securities Fraud Lawsuit Over NHS-Galleri Trial Misrepresentations
- Class Action Lawsuit Filed Against GRAIL Inc.
- Priority Health Partners With GRAIL to Offer Galleri Multi-Cancer Early Detection Test
- GRAIL, Inc. - 8-K Filing
- Grail's Multi-Cancer Blood Test Moves Closer to Real-World Use Despite Trial Setback
- Grail Stock Rises on Optimism for FDA Approval and Insurance Coverage
- Grail Stock Rises on Investor Optimism Despite Mixed ASCO Presentation
- Grail Stock Rises on Investor Optimism Despite Mixed Presentation at ASCO Conference
- Grail Stock Faces Volatility After NHS Trial Results Miss Expectations
- Grail Shares Drop After Mixed Results from NHS-Galleri Trial Presented at ASCO
- GRAIL, Inc. - 8-K Filing
- Grail Shares Drop After Mixed Results from Galleri Test Trial Presented at ASCO
- Grail's Share Price Continues to Decline Amid Unmet Trial Endpoint
- Grail's Share Price Continues Decline Amid Disappointing Trial Results
- Grail Shares Rise Amid Earnings Report and Upcoming ASCO Presentation
- GRAIL, Inc. - 10-Q Filing
- Grail Reports Q1 2026 Earnings with Revenue Growth and Strategic Expansions